Correlation Between Verastem and Day One

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Verastem and Day One at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verastem and Day One into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verastem and Day One Biopharmaceuticals, you can compare the effects of market volatilities on Verastem and Day One and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verastem with a short position of Day One. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verastem and Day One.

Diversification Opportunities for Verastem and Day One

-0.24
  Correlation Coefficient

Very good diversification

The 3 months correlation between Verastem and Day is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Verastem and Day One Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Day One Biopharmaceu and Verastem is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verastem are associated (or correlated) with Day One. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Day One Biopharmaceu has no effect on the direction of Verastem i.e., Verastem and Day One go up and down completely randomly.

Pair Corralation between Verastem and Day One

Given the investment horizon of 90 days Verastem is expected to generate 2.17 times more return on investment than Day One. However, Verastem is 2.17 times more volatile than Day One Biopharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Day One Biopharmaceuticals is currently generating about -0.05 per unit of risk. If you would invest  1,144  in Verastem on December 4, 2024 and sell it today you would lose (590.00) from holding Verastem or give up 51.57% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Verastem  vs.  Day One Biopharmaceuticals

 Performance 
       Timeline  
Verastem 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Verastem are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Verastem displayed solid returns over the last few months and may actually be approaching a breakup point.
Day One Biopharmaceu 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Day One Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Verastem and Day One Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Verastem and Day One

The main advantage of trading using opposite Verastem and Day One positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verastem position performs unexpectedly, Day One can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Day One will offset losses from the drop in Day One's long position.
The idea behind Verastem and Day One Biopharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency